MY
Mayu Yoshikawa
Advisor at ARCH Venture Partners
Tokyo
Overview
Mayu Yoshikawa is a highly accomplished VC and CSO/President in the biotech industry, with a Ph.D. in Biochemistry/Molecular Biology from The University of Tokyo. Notable highlights include serving as a Senior Advisor at ARCH Venture Partners and founding AN Venture Capital, while currently leading a biotech company as President and investing in various sectors such as Robotics, AgTech, and Health IT.
Mayu Yoshikawa's career is marked by significant achievements such as founding a venture capital firm, serving in leadership roles at prominent organizations like A-SEEDS Co., Ltd., and contributing expertise as a consultant at McKinsey & Company. Yoshikawa's diverse experience and educational background underscore a strong foundation in genetics, genotyping, and molecular biology, positioning her as a key player in the biotech and investment sectors.
Work Experience
Senior Advisor
2023 - Current
ARCH is a venture firm that focuses on life science discoveries to prevent, detect, and cure disease.
President
2023
Chief Strategy Officer (CSO)
2023
Founder
2022 - 2023
http://www.an.vc
AN Ventures is a venture capital fund that focuses on building biotech companies.
Executive Officer
2016 - 2022
Co-founder
2014 - 2018
Mobile library project in Tanzania, providing literacy, sex and IT education
Consultant
2014 - 2016
McKinsey Growth Tech serves leading growth stage tech players, venture capital, and growth private equity
Research Internship
2012 - 2012
Optimization of a high throughput genotyping technique that can be applied to emerging drug resistant M. tuberculosis in South Africa.